29 June 2022
Positive data from the clinical phase I MAD study with AlzeCure’s Alzheimer’s project NeuroRestore ACD856
Uppsala Sweden, June 29stCTC Clinical Trial Consultants, a Scandinavian clinical research organization (CRO), and AlzeCure Pharma AB (publ) (FN STO:…